WallStreetZenWallStreetZen

NASDAQ: CDXS
CODEXIS INC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CDXS

Based on 2 analysts offering 12 month price targets for CODEXIS INC.
Min Forecast
$22.00+116.32%
Avg Forecast
$30.00+194.99%
Max Forecast
$38.00+273.65%

Should I buy or sell CDXS stock?

Based on 2 analysts offering ratings for CODEXIS INC.
Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

CDXS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Stephens & Co.
Bottom 20%
20
Strong BuyMaintains$22.00+104.65%2022-05-11
HC Wainwright & Co.
Bottom 24%
24
BuyMaintains$38.00+253.49%2021-11-05

1 of 1

Forecast return on equity

Is CDXS forecast to generate an efficient return?
Company
10.7%
Industry
117.26%
Market
32.44%
CDXS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CDXS forecast to generate an efficient return on assets?
Company
7.22%
Industry
19.5%
CDXS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CDXS earnings per share forecast

What is CDXS's earnings per share in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
-$0.44
Avg 2 year Forecast
-$0.31
Avg 3 year Forecast
$0.03

CDXS revenue forecast

What is CDXS's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$154.9M+26.91%
Avg 2 year Forecast
$173.5M+42.18%
Avg 3 year Forecast
$219.8M+80.09%
CDXS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CDXS revenue growth forecast

How is CDXS forecast to perform vs Biotechnology companies and vs the US market?
Company
20.38%
Industry
18.28%
Market
9.27%
CDXS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CDXS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CDXS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CDXS$10.75$30.00+179.07%Strong Buy
NSTG$15.20$45.67+200.44%Strong Buy
TBPH$9.14$12.67+38.59%Hold
MRUS$16.28$40.67+149.80%Buy
RCKT$10.78$62.00+475.14%Strong Buy
View Top Biotech Stocks

CODEXIS Stock Forecast FAQ

Is CODEXIS Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: CDXS) stock is to Strong Buy CDXS stock.

Out of 2 analysts, 1 (50%) are recommending CDXS as a Strong Buy, 1 (50%) are recommending CDXS as a Buy, 0 (0%) are recommending CDXS as a Hold, 0 (0%) are recommending CDXS as a Sell, and 0 (0%) are recommending CDXS as a Strong Sell.

What is CDXS's earnings growth forecast for 2022-2024?

(NASDAQ: CDXS) CODEXIS's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 8.64%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.83%.

CODEXIS's earnings in 2022 is -$20,567,000.On average, 5 Wall Street analysts forecast CDXS's earnings for 2022 to be -$28,733,786, with the lowest CDXS earnings forecast at -$35,917,233, and the highest CDXS earnings forecast at -$19,591,218. On average, 5 Wall Street analysts forecast CDXS's earnings for 2023 to be -$20,244,259, with the lowest CDXS earnings forecast at -$34,611,152, and the highest CDXS earnings forecast at -$8,489,528.

In 2024, CDXS is forecast to generate $1,959,122 in earnings, with the lowest earnings forecast at -$54,855,410 and the highest earnings forecast at $69,222,304.

What is CDXS's revenue growth forecast for 2022-2024?

(NASDAQ: CDXS) CODEXIS's forecast annual revenue growth rate of 20.38% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 18.28%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 9.27%.

CODEXIS's revenue in 2022 is $122,063,000.On average, 5 Wall Street analysts forecast CDXS's revenue for 2022 to be $10,116,382,543, with the lowest CDXS revenue forecast at $9,998,051,586, and the highest CDXS revenue forecast at $10,297,797,221. On average, 5 Wall Street analysts forecast CDXS's revenue for 2023 to be $11,333,127,789, with the lowest CDXS revenue forecast at $9,998,051,586, and the highest CDXS revenue forecast at $12,304,590,985.

In 2024, CDXS is forecast to generate $14,355,138,469 in revenue, with the lowest revenue forecast at $10,507,423,254 and the highest revenue forecast at $18,908,137,532.

What is CDXS's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: CDXS) forecast ROA is 7.22%, which is lower than the forecast US Biotechnology industry average of 19.5%.

What is CDXS's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CDXS price target, the average CDXS price target is $30.00, with the highest CDXS stock price forecast at $38.00 and the lowest CDXS stock price forecast at $22.00.

On average, Wall Street analysts predict that CODEXIS's share price could reach $30.00 by May 11, 2023. The average CODEXIS stock price prediction forecasts a potential upside of 179.07% from the current CDXS share price of $10.75.

What is CDXS's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: CDXS) CODEXIS's current Earnings Per Share (EPS) is -$0.33. On average, analysts forecast that CDXS's EPS will be -$0.44 for 2022, with the lowest EPS forecast at -$0.55, and the highest EPS forecast at -$0.30. On average, analysts forecast that CDXS's EPS will be -$0.31 for 2023, with the lowest EPS forecast at -$0.53, and the highest EPS forecast at -$0.13. In 2024, CDXS's EPS is forecast to hit $0.03 (min: -$0.84, max: $1.06).

What is CDXS's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: CDXS) forecast ROE is 10.7%, which is considered weak.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending StocksStock Market SectorsStock Market Industries
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.